Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Nephrology
Published in: BMC Nephrology 1/2002

Open Access 01-12-2002 | Case report

Acute bilateral emphysematous pyelonephritis successfully managed by medical therapy alone: A case report and review of the literature

Authors: Guillermo Flores, Haiko Nellen, Francisco Magaña, Juan Calleja

Published in: BMC Nephrology | Issue 1/2002

Login to get access

Abstract

Background

Bilateral emphysematous pyelonephritis is a life threatening condition usually occurring in diabetics. Management of this condition has traditionally been aggressive and surgery is considered mandatory. However, this is itself a hazardous intervention in a septic, unstable patient with circulatory or liver failure. When bilateral disease is present, the need for long-term dialysis is obviously unavoidable.

Case presentation

We herein report one of the few cases of bilateral emphysematous pyelonephritis successfully managed by non-surgical treatment.
Appendix
Available only for authorised users
Literature
1.
2.
Zabbo A, Montie JL, Popowniak KL, et al: Bilateral emphysematous pyelonephritis. Urology. 1985, 25: 293-6.CrossRefPubMed
3.
Ahlering TE, Boyd SD, Hamilton CL, et al: Emphysematous pyelonephritis: a 5-year experience with 13 patients. J Urol. 1985, 134: 1086-8.PubMed
4.
Ballanger P, Petit J, Thomas G, Tauzin-Fin P: La pyelonephrite emphysemateuse. Revue de la litterature a propos de quatre nouveaux cas. Ann Urol (Paris). 1986, 20: 195-200.
5.
Dunn SR, Dewolf WC, Gonzalez R: Emphysematous pyelonephritis: report of 3 cases treated by nephrectomy. J Urol. 1975, 114: 348-50.PubMed
6.
Picron B, Mauerhoff T, Farchakh E, et al: Pyelonephrite emphysemateuse (P.N.E.) chez une patiente diabetique. Revue de la litterature a propos d'un cas. Acta Clin Belg. 1991, 46: 94-9.CrossRefPubMed
7.
Campbell's Urology Walsh, Patrick C 7th ed Cloth Text. 1997
8.
Ouellet LM, Brook MP: Emphysematous pyelonephritis: an emergency indication for the plain abdominal radiograph. Ann Emerg Med. 1988, 17: 722-4.CrossRefPubMed
9.
Evanoff GV, Thompson CS, Foley R, et al: Spectrum of gas within the kidney. Emphysematous pyelonephritis and emphysematous pyelitis. Am J Med. 1987, 83: 149-54.CrossRefPubMed
10.
Michaeli J, Mogle P, Perlberg S, et al: Emphysematous pyelonephritis. J Urol. 1984, 131: 203-8.PubMed
11.
Chen KW, Huang JJ, Wu MH, et al: Gas in hepatic veins: a rare and critical presentation of emphysematous pyelonephritis. J Urol. 1994, 151: 125-6.PubMed
12.
Cook DJ, Achong MR, Dobranowski J: Emphysematous pyelonephritis. Complicated urinary tract infection in diabetes. Diabetes Care. 1989, 12: 229-32.CrossRefPubMed
13.
Andersen JB: Pyelonephritis emphysematosa. En alvorlig komplikation til diabetes mellitus. Ugeskr Laeger. 1992, 154: 1419-21.PubMed
14.
Joris L, van Daele G, Timmermans U, et al: Emphysematous pyelonephritis. Intensive Care Med. 1989, 15: 206-8.CrossRefPubMed
15.
Huang JJ, Tseng CC: Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med. 2000, 160: 797-805. 10.1001/archinte.160.6.797.CrossRefPubMed
16.
Hui L, Tokeshi J: Emphysematous pyelonephritis. Hawaii Med J. 2000, 59: 336-7.PubMed
17.
Chen MT, Huang CN, Chou YH, et al: Percutaneous drainage in the treatment of emphysematous pyelonephritis: 10-year experience. J Urol. 1997, 157: 1569-73. 10.1097/00005392-199705000-00008.CrossRefPubMed
18.
Shokeir AA, El-Azab M, Mohsen T, et al: Emphysematous pyelonephritis: a 15-year experience with 20 cases. Urology. 1997, 49: 343-6. 10.1016/S0090-4295(96)00501-8.CrossRefPubMed
19.
Tahir H, Thomas G, Sheerin N, et al: Successful medical treatment of acute bilateral emphysematous pyelonephritis. Am J Kidney Dis. 2000, 36: 1267-70.CrossRefPubMed
20.
Kondo T, Okuda H, Suzuki M, et al: [A case of emphysematous pyelonephritis improved with conservative therapy–indication for conservative therapy]. Hinyokika Kiyo. 2000, 46: 335-8.PubMed
21.
Labussiere AS, Gazaigne J, Walker P, Laplace M: Pyelonephrite emphysemateuse. Un cas traite medicalement. J Urol (Paris). 1996, 102: 127-9.
22.
Punnose J, Yahya TM, Premchandran JS, et al: Emphysematous pyelonephritis responding to medical therapy. Int J Clin Pract. 1997, 51: 468-70.PubMed
23.
Jain SK, Agarwal N, Chaturvedi SK: Emphysematous pyelonephritis: a rare presentation. J Postgrad Med. 2000, 46: 31-2.PubMed
24.
Best CD, Terris MK, Tacker JR, et al: Clinical and radiological findings in patients with gas forming renal abscess treated conservatively. J Urol. 1999, 162: 1273-6. 10.1097/00005392-199910000-00007.CrossRefPubMed
25.
Angulo JC, Dehaini A, Escribano J, et al: Successful conservative management of emphysematous pyelonephritis, bilateral or in a solitary kidney. Scand J Urol Nephrol. 1997, 31: 193-7.CrossRefPubMed
26.
Grozel F, Berthezene Y, Guerin C, et al: Bilateral emphysematous pyelonephritis resolving to medical therapy: demonstration by US and CT. Eur Radiol. 1997, 7: 844-6. 10.1007/s003300050216.CrossRefPubMed
27.
Shimizu H, Hariu K, Kamiyama Y, et al: Bilateral emphysematous pyelonephritis with autosomal-dominant polycystic kidney disease successfully treated by conservative method. Urol Int. 1999, 63: 252-4. 10.1159/000030462.CrossRefPubMed
Metadata
Title
Acute bilateral emphysematous pyelonephritis successfully managed by medical therapy alone: A case report and review of the literature
Authors
Guillermo Flores
Haiko Nellen
Francisco Magaña
Juan Calleja
Publication date
01-12-2002
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2002
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-3-4

Other articles of this Issue 1/2002

BMC Nephrology 1/2002 Go to the issue

Research article

Activation of the Fas/Fas ligand pathway in hypertensive renal disease in Dahl/Rapp rats

Research article

A multidisciplinary program for achieving lipid goals in chronic hemodialysis patients

Research article

Polycystic kidney disease in patients on the renal transplant waiting list: trends in hematocrit and survival

Case report

Nephropathic cystinosis associated with cardiomyopathy: A 27-year clinical follow-up

Research article

Hospitalized poisonings after renal transplantation in the United States

Research article

Sex steroids do not affect shigatoxin cytotoxicity on human renal tubular or glomerular cells
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits